Categories: News

MDpanel Announces Acquisition of Media Referral, Expanding Presence in New York

NEW YORK, Jan. 7, 2026 /PRNewswire/ — MDpanel, a leading provider of expert medical opinions in North America, today announced the acquisition of Media Referral, a New York-based independent medical examination and peer review organization servicing insurance carriers, self-insured companies, third-party administrators, and attorneys across New York and the broader Mid-Atlantic region.

MDpanel announced the acquisition of Media Referral, further broadening the company’s suite of medical review services.

The acquisition significantly expands MDpanel’s geographic footprint in the Mid-Atlantic and brings a roster of established, blue-chip insurance carrier clients. In addition, the transaction enables MDpanel to expand its peer review services, further broadening the company’s comprehensive suite of medical review services.

“Media Referral has built a strong reputation for quality, responsiveness, and trusted relationships with its clients,” said Jason Erdell, CEO of MDpanel. “New York is one of the most complex medical opinion markets in the country. Media Referral has consistently succeeded in this important market where even large national players have struggled or opted out entirely. This combination further validates MDpanel’s commitment to support medical opinions across all markets within the United States. Our world-class technology suite will allow us to service Media Referral’s premier clients better than ever before.”

Media Referral will continue to operate with its existing management team, ensuring continuity for clients and partners. Over time, the business will benefit from MDpanel’s ongoing investments in technology, infrastructure, and service enhancements, creating a stronger, more scalable platform.

“By joining MDpanel, we are able to offer our clients access to a broader range of services, geographies, and more advanced technologies, while maintaining the service standards they expect,” said Arlene Schechter and Linda Ackerman, Co-CEOs of Media Referral. “This partnership positions us to deliver even greater value as client needs continue to evolve.”

This transaction marks MDpanel’s 10th acquisition and reflects its continued strategy of partnering with and acquiring high-quality organizations that deepen regional coverage, expand service offerings, and enhance the overall client experience.

About MDpanel
MDpanel is the leading provider of expert medical opinions in the United States, serving physicians across a range of specialties. MDpanel is committed to being the partner of choice for physicians, carriers, attorneys and injured workers by connecting those in need of medical opinions with the most qualified and highly regarded medical professionals. For more information about MDpanel, please visit www.mdpanel.com.

Media Contact
David Liao
VP of Corporate Development
MDpanel
david.liao@mdpanel.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/mdpanel-announces-acquisition-of-media-referral-expanding-presence-in-new-york-302654204.html

SOURCE MDpanel

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

5 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

8 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

8 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

8 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

8 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

8 hours ago